Public list Pharma Startups (4732):
FlexGen is working towards the commercialization of a fast and flexible custom microarray synthesis instrument for genomic selection in sequencing and other applications.
Company (Alive / Active)
|Investor||Investor Type||Location||Participating Rounds|
|Cambridge, Massachusetts, United States||Alive / Active||Helicos BioSciences is a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets. Helicos' proprietary True Single Molecule Sequencing, tSMS, technology allows direct measurement of billions of strands of DNA enabling scientists to perform experiments and ask questions never before possible. Helicos is a recipient of two $1,000 genome grants and committed to providing scientists the tools to unlock the era of genomic medic...Show all||Login to see details|
|Spokane, Washington, United States||Alive / Active||Signature Genomic Laboratories aims to use microarray technology to help diagnose chromosome abnormal disabilities in children with developmental disabilities||Login to see details|
|Title||Application Date||Patent Date||Status
(Patent / Application)